Imago BioSciences Inc. (IMGO) NASDAQ

$36.01 0.01 (0.03%)

Market Cap: -

As of 01/10/23 04:00 PM EST. Market closed.

(IMGO)

Imago BioSciences Inc. (IMGO)
NASDAQ

$36.01
0.01 (0.03%)

Market Cap: -

As of 01/10/23 04:00 PM EST. Market closed.

Add to Portfolio

Imago BioSciences is a clinical-stage biopharmaceutical company discovering and developing novel small molecule product candidates that target lysine-specific demethylase 1 (LSD1), an enzyme that plays a central role in the production of blood cells in the bone marrow. Imago is focused on improving the quality and length of life for patients with cancer and bone marrow diseases. Bomedemstat, an ... read more

Imago BioSciences is a clinical-stage biopharmaceutical company discovering and developing novel small molecule product candidates that target lysine-specific demethylase 1 (LSD1), an enzyme that plays a central role in the production of blood cells in the bone marrow. Imago is focused on improving the quality and length of life for patients with cancer and bone marrow diseases. Bomedemstat, an orally available, small molecule inhibitor of LSD1, is the lead product candidate discovered by Imago for the treatment of certain myeloproliferative neoplasms (MPNs), a family of related, chronic cancers of the bone marrow. Imago is evaluating Bomedemstat as a potentially disease-modifying therapy in two Phase 2 clinical trials for the treatment of essential thrombocythemia (NCT04254978) and myelofibrosis (NCT03136185). Bomedemstat has U.S. FDA Orphan Drug and Fast Track Designation for the treatment of ET and MF, European Medicines Agency (EMA) Orphan Designation for the treatment of ET and MF, and PRIority MEdicines (PRIME) Designation by the EMA for the treatment of MF. The company is based in South San Francisco, California. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
2,021
Address
.
PRICE CHART FOR IMAGO BIOSCIENCES INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$36
Days Range
$35.99 - $36.02
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
33,822,201
Open
-
Previous Close
$36
Days Range
$35.99 - $36.02
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
33,822,201
FINANCIAL STATEMENTS FOR IMAGO BIOSCIENCES INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR IMAGO BIOSCIENCES INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Tapper Amy E.Chief, Technical OperationsJan 11, 2023 Option Exercise$36.00141,0945,079,3840Jan 11, 2023, 04:19 PM
Rienhoff Hugh JRChief Executive OfficerJan 11, 2023 Option Exercise$36.00501,70218,061,2720Jan 11, 2023, 04:17 PM
Eichorn Laura G.Chief Financial OfficerJan 11, 2023 Option Exercise$36.00246,4538,872,3080Jan 11, 2023, 04:17 PM
HENNER DENNISDirectorJan 11, 2023 Option Exercise$36.0026,095939,4200Jan 11, 2023, 04:16 PM
Arenberg MichaelSee RemarksJan 11, 2023 Option Exercise$36.0051,5321,855,1520Jan 11, 2023, 04:16 PM
Chiang HsiangyiSenior Vice President, FinanceJan 11, 2023 Option Exercise$36.0026,538955,3680Jan 11, 2023, 04:13 PM
Peppe JenniferSee RemarksJan 11, 2023 Option Exercise$36.00150,1885,406,7680Jan 11, 2023, 04:12 PM
Baltera Robert Jr.DirectorJan 11, 2023 Option Exercise$36.0085030,6000Jan 11, 2023, 04:10 PM
Chiang HsiangyiSenior Vice President FinanceJan 04, 2023 Option Exercise$4.2019,94183,75226,538Jan 05, 2023, 04:31 PM
Arenberg MichaelSee RemarksJan 03, 2023 Option Exercise$15.452,14533,14051,532Jan 05, 2023, 04:30 PM
Peppe JenniferSee RemarksJan 03, 2023 Option Exercise$22.761,37931,386150,188Jan 05, 2023, 04:29 PM
Eichorn Laura G.Chief Financial OfficerJan 03, 2023 Option Exercise$4.0537,119150,176246,453Jan 05, 2023, 04:29 PM
Tapper Amy E.See RemarksJan 03, 2023 Option Exercise$4.8121,261102,321141,094Jan 05, 2023, 04:28 PM
Rienhoff Hugh JRChief Executive OfficerJan 03, 2023 Option Exercise$2.5212,17630,684501,702Jan 05, 2023, 04:27 PM
Eichorn Laura G.Chief Financial OfficerDec 27, 2022 Option Exercise$2.523,1007,812210,837Dec 29, 2022, 04:07 PM
Eichorn Laura G.Chief Financial OfficerDec 27, 2022 Sale$35.933,100111,384207,737Dec 29, 2022, 04:07 PM
Arenberg MichaelSee RemarksDec 27, 2022 Option Exercise$17.5595,0001,667,464119,895Dec 29, 2022, 04:06 PM
Arenberg MichaelSee RemarksDec 27, 2022 Sale$35.9370,5082,533,35249,387Dec 29, 2022, 04:06 PM
Tapper Amy E.See RemarksDec 16, 2022 Option Exercise$2.19100,302219,819219,349Dec 20, 2022, 04:19 PM
Tapper Amy E.See RemarksDec 16, 2022 Sale$35.78100,3023,588,725119,047Dec 20, 2022, 04:19 PM
Arenberg MichaelSee RemarksDec 16, 2022 Option Exercise$15.4572,6451,122,36572,645Dec 20, 2022, 04:18 PM
Arenberg MichaelSee RemarksDec 16, 2022 Sale$35.7847,7501,708,50024,895Dec 20, 2022, 04:18 PM
Peppe JenniferSee RemarksDec 15, 2022 Option Exercise$4.45119,422532,008268,231Dec 19, 2022, 04:27 PM
Peppe JenniferSee RemarksDec 15, 2022 Sale$35.80119,4224,275,236148,809Dec 19, 2022, 04:27 PM
Peppe JenniferSee RemarksDec 15, 2022 Option Exercise$4.45119,422532,008268,231Dec 19, 2022, 04:19 PM
Peppe JenniferSee RemarksDec 15, 2022 Sale$35.80119,4224,275,236148,809Dec 19, 2022, 04:19 PM
Rienhoff Hugh JRChief Executive OfficerDec 15, 2022 Option Exercise$2.18206,309449,246695,835Dec 19, 2022, 04:11 PM
Rienhoff Hugh JRChief Executive OfficerDec 16, 2022 Option Exercise$2.14266,784572,127756,310Dec 19, 2022, 04:11 PM
Rienhoff Hugh JRChief Executive OfficerDec 16, 2022 Sale$35.78266,7849,545,078489,526Dec 19, 2022, 04:11 PM
Rienhoff Hugh JRChief Executive OfficerDec 15, 2022 Sale$35.80206,3097,385,945489,526Dec 19, 2022, 04:11 PM
Eichorn Laura G.Chief Financial OfficerDec 15, 2022 Option Exercise$2.21126,714279,813334,451Dec 19, 2022, 04:10 PM
Eichorn Laura G.Chief Financial OfficerDec 15, 2022 Sale$35.79126,7144,535,170207,737Dec 19, 2022, 04:10 PM
Tapper Amy E.See RemarksNov 02, 2022 Option Exercise$2.527501,890119,797Nov 04, 2022, 08:20 PM
Tapper Amy E.See RemarksNov 02, 2022 Sale$17.9075013,425119,047Nov 04, 2022, 08:20 PM
Eichorn Laura G.Chief Financial OfficerNov 02, 2022 Option Exercise$2.525531,394208,290Nov 04, 2022, 08:18 PM
Eichorn Laura G.Chief Financial OfficerNov 02, 2022 Sale$18.005539,954207,737Nov 04, 2022, 08:18 PM
Eichorn Laura G.Chief Financial OfficerAug 22, 2022 Option Exercise$2.524471,126208,184Aug 24, 2022, 06:24 PM
Eichorn Laura G.Chief Financial OfficerAug 22, 2022 Sale$18.004478,046207,737Aug 24, 2022, 06:24 PM
Eichorn Laura G.See RemarksAug 16, 2022 Option Exercise$2.525331,343208,270Aug 18, 2022, 05:50 PM
Eichorn Laura G.See RemarksAug 17, 2022 Option Exercise$2.52373940208,110Aug 18, 2022, 05:50 PM
Eichorn Laura G.See RemarksAug 17, 2022 Sale$19.503737,274207,737Aug 18, 2022, 05:50 PM
Eichorn Laura G.See RemarksAug 16, 2022 Sale$19.5053310,394207,737Aug 18, 2022, 05:50 PM
Peppe JenniferSee RemarksAug 16, 2022 Option Exercise$2.526,40216,133155,211Aug 17, 2022, 05:05 PM
Peppe JenniferSee RemarksAug 16, 2022 Sale$19.416,402124,280148,809Aug 17, 2022, 05:05 PM
Peppe JenniferSee RemarksAug 15, 2022 Option Exercise$2.525,59814,107154,407Aug 16, 2022, 04:08 PM
Peppe JenniferSee RemarksAug 15, 2022 Sale$19.415,598108,636148,809Aug 16, 2022, 04:08 PM
Tapper Amy E.See RemarksAug 12, 2022 Option Exercise$2.527501,890119,797Aug 16, 2022, 04:06 PM
Tapper Amy E.See RemarksAug 15, 2022 Option Exercise$2.5211,50028,980130,547Aug 16, 2022, 04:06 PM
Tapper Amy E.See RemarksAug 12, 2022 Sale$17.9075013,425119,047Aug 16, 2022, 04:06 PM
Tapper Amy E.See RemarksAug 15, 2022 Sale$19.2611,500221,545119,047Aug 16, 2022, 04:06 PM
Eichorn Laura G.See RemarksJul 20, 2022 Option Exercise$2.521,0002,520208,737Jul 21, 2022, 05:50 PM
Eichorn Laura G.See RemarksJul 20, 2022 Sale$18.001,00018,000207,737Jul 21, 2022, 05:50 PM
Tapper Amy E.See RemarksJul 20, 2022 Option Exercise$2.527501,890119,797Jul 21, 2022, 05:49 PM
Tapper Amy E.See RemarksJul 20, 2022 Sale$17.9075013,425119,047Jul 21, 2022, 05:49 PM
Hong Wan-JenChief Medical OfficerJul 18, 2022 Option Exercise$7.061,0007,0601,000Jul 20, 2022, 05:39 PM
Eichorn Laura G.See RemarksFeb 22, 2022 Option Exercise$2.528,00020,160215,737Feb 24, 2022, 06:05 PM
Eichorn Laura G.See RemarksFeb 22, 2022 Sale$21.608,000172,813208,137Feb 24, 2022, 06:05 PM
Peppe JenniferSee RemarksFeb 11, 2022 Option Exercise$2.107,00014,700155,809Feb 15, 2022, 04:26 PM
Peppe JenniferSee RemarksFeb 11, 2022 Sale$23.767,000166,295148,809Feb 15, 2022, 04:26 PM
Eichorn Laura G.See RemarksFeb 11, 2022 Option Exercise$1.524,0006,080211,737Feb 15, 2022, 04:25 PM
Eichorn Laura G.See RemarksFeb 11, 2022 Sale$23.614,00094,455207,737Feb 15, 2022, 04:25 PM
Peppe JenniferSee RemarksFeb 09, 2022 Option Exercise$1.8610,00018,574158,809Feb 11, 2022, 04:23 PM
Peppe JenniferSee RemarksFeb 09, 2022 Sale$22.2610,000222,581148,809Feb 11, 2022, 04:23 PM
Eichorn Laura G.See RemarksFeb 09, 2022 Option Exercise$1.524,0006,080211,737Feb 11, 2022, 04:22 PM
Eichorn Laura G.See RemarksFeb 09, 2022 Sale$21.564,00086,254207,737Feb 11, 2022, 04:22 PM
Tapper Amy E.See RemarksFeb 09, 2022 Option Exercise$1.523,0004,560122,047Feb 11, 2022, 04:21 PM
Tapper Amy E.See RemarksFeb 09, 2022 Sale$21.543,00064,614119,047Feb 11, 2022, 04:21 PM
Peppe JenniferSee RemarksFeb 07, 2022 Option Exercise$1.9813,00025,760161,809Feb 09, 2022, 04:06 PM
Peppe JenniferSee RemarksFeb 07, 2022 Sale$20.4813,000266,202154,709Feb 09, 2022, 04:06 PM
Tapper Amy E.See RemarksFeb 01, 2022 Option Exercise$2.106,50013,650125,547Feb 03, 2022, 04:13 PM
Tapper Amy E.See RemarksFeb 01, 2022 Sale$19.766,500128,412119,797Feb 03, 2022, 04:13 PM
Peppe JenniferSee RemarksJan 12, 2022 Option Exercise$1.7914,00025,059162,809Jan 14, 2022, 06:48 PM
Peppe JenniferSee RemarksJan 12, 2022 Sale$19.9514,000279,353148,809Jan 14, 2022, 06:48 PM
Tapper Amy E.See RemarksJan 12, 2022 Option Exercise$1.526,0009,120125,047Jan 14, 2022, 06:47 PM
Tapper Amy E.See RemarksJan 12, 2022 Sale$19.966,000119,750119,047Jan 14, 2022, 06:47 PM
Eichorn Laura G.See RemarksJan 12, 2022 Option Exercise$1.528,00012,160215,737Jan 14, 2022, 06:46 PM
Eichorn Laura G.See RemarksJan 12, 2022 Sale$19.968,000159,651207,737Jan 14, 2022, 06:46 PM
Clarus Lifesciences III, L.P.10% OwnerJul 20, 2021 Buy$16.00150,0002,400,0003,375,037Jul 20, 2021, 06:05 PM
Heron Patrick JDirectorJul 20, 2021 Buy$16.00187,5003,000,000145,918Jul 20, 2021, 05:54 PM
Omega Fund VI, L.P.Former 10% ownerJul 15, 2021 Buy$16.00250,0004,000,000250,000Jul 19, 2021, 07:03 PM
Baltera Robert Jr.DirectorJul 15, 2021 Buy$16.0085013,600850Jul 19, 2021, 04:09 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Tapper Amy E.Chief, Technical Operations01/11/20235,079,384
Rienhoff Hugh JRChief Executive Officer01/11/202318,061,272
Eichorn Laura G.Chief Financial Officer01/11/20238,872,308
HENNER DENNISDirector01/11/2023939,420
Arenberg MichaelSee Remarks01/11/20231,855,152
Chiang HsiangyiSenior Vice President, Finance01/11/2023955,368
Peppe JenniferSee Remarks01/11/20235,406,768
Baltera Robert Jr.Director01/11/202330,600
Chiang HsiangyiSenior Vice President Finance01/04/202383,752
Arenberg MichaelSee Remarks01/03/202333,140
Peppe JenniferSee Remarks01/03/202331,386
Eichorn Laura G.Chief Financial Officer01/03/2023150,176
Tapper Amy E.See Remarks01/03/2023102,321
Rienhoff Hugh JRChief Executive Officer01/03/202330,684
Eichorn Laura G.Chief Financial Officer12/27/20227,812
Eichorn Laura G.Chief Financial Officer12/27/2022111,384
Arenberg MichaelSee Remarks12/27/20221,667,464
Arenberg MichaelSee Remarks12/27/20222,533,352
Tapper Amy E.See Remarks12/16/2022219,819
Tapper Amy E.See Remarks12/16/20223,588,725
Arenberg MichaelSee Remarks12/16/20221,122,365
Arenberg MichaelSee Remarks12/16/20221,708,500
Peppe JenniferSee Remarks12/15/2022532,008
Peppe JenniferSee Remarks12/15/20224,275,236
Peppe JenniferSee Remarks12/15/2022532,008
Peppe JenniferSee Remarks12/15/20224,275,236
Rienhoff Hugh JRChief Executive Officer12/15/2022449,246
Rienhoff Hugh JRChief Executive Officer12/16/2022572,127
Rienhoff Hugh JRChief Executive Officer12/16/20229,545,078
Rienhoff Hugh JRChief Executive Officer12/15/20227,385,945
Eichorn Laura G.Chief Financial Officer12/15/2022279,813
Eichorn Laura G.Chief Financial Officer12/15/20224,535,170
Tapper Amy E.See Remarks11/02/20221,890
Tapper Amy E.See Remarks11/02/202213,425
Eichorn Laura G.Chief Financial Officer11/02/20221,394
Eichorn Laura G.Chief Financial Officer11/02/20229,954
Eichorn Laura G.Chief Financial Officer08/22/20221,126
Eichorn Laura G.Chief Financial Officer08/22/20228,046
Eichorn Laura G.See Remarks08/16/20221,343
Eichorn Laura G.See Remarks08/17/2022940
Eichorn Laura G.See Remarks08/17/20227,274
Eichorn Laura G.See Remarks08/16/202210,394
Peppe JenniferSee Remarks08/16/202216,133
Peppe JenniferSee Remarks08/16/2022124,280
Peppe JenniferSee Remarks08/15/202214,107
Peppe JenniferSee Remarks08/15/2022108,636
Tapper Amy E.See Remarks08/12/20221,890
Tapper Amy E.See Remarks08/15/202228,980
Tapper Amy E.See Remarks08/12/202213,425
Tapper Amy E.See Remarks08/15/2022221,545
Eichorn Laura G.See Remarks07/20/20222,520
Eichorn Laura G.See Remarks07/20/202218,000
Tapper Amy E.See Remarks07/20/20221,890
Tapper Amy E.See Remarks07/20/202213,425
Hong Wan-JenChief Medical Officer07/18/20227,060
Eichorn Laura G.See Remarks02/22/202220,160
Eichorn Laura G.See Remarks02/22/2022172,813
Peppe JenniferSee Remarks02/11/202214,700
Peppe JenniferSee Remarks02/11/2022166,295
Eichorn Laura G.See Remarks02/11/20226,080
Eichorn Laura G.See Remarks02/11/202294,455
Peppe JenniferSee Remarks02/09/202218,574
Peppe JenniferSee Remarks02/09/2022222,581
Eichorn Laura G.See Remarks02/09/20226,080
Eichorn Laura G.See Remarks02/09/202286,254
Tapper Amy E.See Remarks02/09/20224,560
Tapper Amy E.See Remarks02/09/202264,614
Peppe JenniferSee Remarks02/07/202225,760
Peppe JenniferSee Remarks02/07/2022266,202
Tapper Amy E.See Remarks02/01/202213,650
Tapper Amy E.See Remarks02/01/2022128,412
Peppe JenniferSee Remarks01/12/202225,059
Peppe JenniferSee Remarks01/12/2022279,353
Tapper Amy E.See Remarks01/12/20229,120
Tapper Amy E.See Remarks01/12/2022119,750
Eichorn Laura G.See Remarks01/12/202212,160
Eichorn Laura G.See Remarks01/12/2022159,651
Clarus Lifesciences III, L.P.10% Owner07/20/20212,400,000
Heron Patrick JDirector07/20/20213,000,000
Omega Fund VI, L.P.Former 10% owner07/15/20214,000,000
Baltera Robert Jr.Director07/15/202113,600
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR IMAGO BIOSCIENCES INC
LOADING...